NASDAQ:ICCC ImmuCell (ICCC) Stock Price, News & Analysis → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free ICCC Stock Alerts $4.99 -0.26 (-4.95%) (As of 03/18/2024 ET) Add Compare Share Share Today's Range$4.98▼$5.1050-Day Range$4.90▼$5.4752-Week Range$4.26▼$6.05Volume22,024 shsAverage Volume6,060 shsMarket Capitalization$38.67 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get ImmuCell alerts: Email Address Ad InvestorPlaceThey said crypto was dead. It went up 100X.Bitcoin’s haters are out again. Despite the price doubling in the last six months alone… That hasn’t stopped the experts from piling on. Warren Buffett’s right-hand man Charlie Munger called crypto investors “idiots” in one of his last interviews. JPMorgan CEO Jamie Dimon, recently called Bitcoin a “pet rock” and “a hyped-up fraud.” But when it comes to cryptos, these are exactly the people you shouldn’t listen to. They’ve predicted crypto’s demise for years.There are five coins you must take a look at right away. About ImmuCell Stock (NASDAQ:ICCC)ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. In addition, it is involved in developing Re-Tain, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.Read More ICCC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ICCC Stock News HeadlinesMarch 19, 2024 | americanbankingnews.comImmuCell (NASDAQ:ICCC) Shares Cross Above 200 Day Moving Average of $5.00February 29, 2024 | finance.yahoo.comImmuCell Corporation (NASDAQ:ICCC) Q4 2023 Earnings Call TranscriptMarch 19, 2024 | Paradigm Press (Ad)8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)THIS cryptocurrency has gained 40% in 6 months. A crypto millionaire who has researched the space for a decade says it will go up 8,788% in 5 years. The name of this cryptocurrency is revealed right here: February 28, 2024 | seekingalpha.comImmuCell Corporation (ICCC) Q4 2023 Earnings Call TranscriptFebruary 27, 2024 | globenewswire.comImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023February 16, 2024 | finance.yahoo.comImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023February 16, 2024 | globenewswire.comImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023January 9, 2024 | benzinga.comImmuCell Stock (NASDAQ:ICCC) Dividends: History, Yield and DatesMarch 19, 2024 | Prosper Trading Academy (Ad)Did you make $29,000 two days with AI options trades?What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:January 9, 2024 | finanznachrichten.deImmuCell Corporation: ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023January 8, 2024 | msn.comImmuCell says total sale for year ended December falls 6% Y/YJanuary 8, 2024 | finance.yahoo.comImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023November 15, 2023 | finance.yahoo.comImmuCell Corporation (NASDAQ:ICCC) Q3 2023 Earnings Call TranscriptNovember 14, 2023 | seekingalpha.comImmuCell Corporation (ICCC) Q3 2023 Earnings Call TranscriptNovember 13, 2023 | msn.comImmuCell GAAP EPS of -$0.12, revenue of $5.39MNovember 13, 2023 | finance.yahoo.comImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023November 7, 2023 | finance.yahoo.comImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023October 5, 2023 | finance.yahoo.comImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023September 5, 2023 | finance.yahoo.comImmuCell Corporation (ICCC) Stock Historical Prices & Data - Yahoo FinanceAugust 29, 2023 | finance.yahoo.comImmuCell Announces Submission of CMC Technical Section to the FDAAugust 11, 2023 | seekingalpha.comImmuCell Corporation (ICCC) Q2 2023 Earnings Call TranscriptAugust 11, 2023 | finance.yahoo.comImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2023August 8, 2023 | finance.yahoo.comImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2023July 12, 2023 | msn.comDisney's India Plan - $DIS $ANGO $MLKN $ICCC $AZTRJuly 12, 2023 | finanznachrichten.deImmuCell Corporation: ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2023July 11, 2023 | seekingalpha.comImmuCell preliminary Q2 revenue falls 9% Y/YJuly 11, 2023 | finance.yahoo.comImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2023See More Headlines Receive ICCC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ImmuCell and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/12/2021Today3/19/2024Next Earnings (Estimated)5/09/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Diagnostic substances Sub-IndustryN/A Current SymbolNASDAQ:ICCC CUSIPN/A CIK811641 Webwww.immucell.com Phone(207) 878-2770Fax207-878-2117Employees72Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.75) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-5,780,000.00 Net Margins-33.05% Pretax Margin-38.67% Return on Equity-21.38% Return on Assets-13.16% Debt Debt-to-Equity Ratio0.42 Current Ratio3.59 Quick Ratio1.37 Sales & Book Value Annual Sales$17.47 million Price / Sales2.21 Cash Flow$0.00 per share Price / Cash Flow39,897.74 Book Value$3.92 per share Price / Book1.27Miscellaneous Outstanding Shares7,750,000Free Float7,259,000Market Cap$38.67 million OptionableNot Optionable Beta0.58 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Michael F. Brigham (Age 63)President, CEO, Principal Financial Officer, Treasurer, Secretary & Director Comp: $595.44kMs. Bobbi Jo Brockmann (Age 47)VP of Sales & Marketing and Director Comp: $287.68kElizabeth S. ToothakerDirector of Finance & AdministrationMr. A. Gustavo ScaffaSenior Director of QualityJohn W. ZinckgrafDirector of Product DevelopmentKey CompetitorsAspira Women's HealthNASDAQ:AWHCardio DiagnosticsNASDAQ:CDIOOncoCyteNASDAQ:OCXARCA biopharmaNASDAQ:ABIOTrinity BiotechNASDAQ:TRIBView All CompetitorsInstitutional OwnershipNorthern Trust CorpBought 19,781 shares on 2/13/2024Ownership: 0.421%View All Institutional Transactions ICCC Stock Analysis - Frequently Asked Questions How have ICCC shares performed in 2024? ImmuCell's stock was trading at $5.09 at the beginning of the year. Since then, ICCC stock has decreased by 2.0% and is now trading at $4.99. View the best growth stocks for 2024 here. Are investors shorting ImmuCell? ImmuCell saw a drop in short interest during the month of February. As of February 29th, there was short interest totaling 6,300 shares, a drop of 20.3% from the February 14th total of 7,900 shares. Based on an average daily volume of 8,400 shares, the short-interest ratio is currently 0.8 days. Currently, 0.1% of the company's shares are short sold. View ImmuCell's Short Interest. When is ImmuCell's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our ICCC earnings forecast. How were ImmuCell's earnings last quarter? ImmuCell Co. (NASDAQ:ICCC) posted its quarterly earnings data on Thursday, August, 12th. The biotechnology company reported $0.02 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.08) by $0.10. The biotechnology company had revenue of $4.54 million for the quarter. ImmuCell had a negative net margin of 33.05% and a negative trailing twelve-month return on equity of 21.38%. What guidance has ImmuCell issued on next quarter's earnings? ImmuCell updated its fourth quarter 2023 earnings guidance on Monday, January, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $5.1 million-$5.1 million, compared to the consensus revenue estimate of $5.4 million. What other stocks do shareholders of ImmuCell own? Based on aggregate information from My MarketBeat watchlists, some companies that other ImmuCell investors own include VBI Vaccines (VBIV), Sorrento Therapeutics (SRNE), Agile Therapeutics (AGRX), Biocept (BIOC), Amarin (AMRN), CRISPR Therapeutics (CRSP), Genocea Biosciences (GNCA), Idera Pharmaceuticals (IDRA) and Pfizer (PFE). Who are ImmuCell's major shareholders? ImmuCell's stock is owned by a number of institutional and retail investors. Top institutional investors include Northern Trust Corp (0.42%). View institutional ownership trends. How do I buy shares of ImmuCell? Shares of ICCC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:ICCC) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaThe AI Bottleneck No One is Talking AboutThe Bull ReportMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmuCell Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.